2020年三季度发表的生信SCI，按照期刊接收的文章数量排序，TOP10的期刊是：OncolLett（2.31分）、FrontOncol（4.85分）、BiomedRes Int（2.28分）、CancerCell Int（4.18分）、Aging (Albany NY)（4.83分）、Cancers （6.126分）、Int J Immunopharmacol（3.94分）、Front Genet（3.26 分）、J CELL MOL MED（4.49分）、OncoTargets Ther（3.34分）。（小编惊喜的发现这个排名与2020年上半年生信SCI友好期刊排名竟大同小异，果然称得上生信友好期刊！）
2020生信友好期刊 | 接收量 | 最新IF |
OncolLett | 49 | 2.311 |
FrontOncol | 48 | 4.848 |
BiomedRes Int | 40 | 2.276 |
CancerCell Int | 35 | 4.175 |
Aging (Albany NY) | 34 | 4.83 |
Cancers | 32 | 6.126 |
Int J Immunopharmacol | 31 | 3.943 |
Front Genet | 27 | 3.258 |
J CELL MOL MED | 26 | 4.486 |
OncoTargets Ther | 26 | 3.337 |
Biosci Rep | 23 | 2.942 |
Cancer Med | 23 | 3.491 |
Medicine | 23 | 1.552 |
Sci Rep | 23 | 3.998 |
J Cancer | 22 | 3.565 |
BMC cancer | 19 | 3.150 |
Mol Med Rep | 17 | 2.100 |
Am J Transl Res | 15 | 3.375 |
Cancer Manag Res | 15 | 2.886 |
DNA Cell Biol | 15 | 3.191 |
Med Sci Monitor | 15 | 1.92 |
Genomics | 14 | 6.205 |
Theranostics | 14 | 8.579 |
Gene | 13 | 2.984 |
J Transl Med | 13 | 4.124 |
Oncol Rep | 13 | 3.417 |
Exp Ther Med | 12 | 1.785 |
Pathol Res Pract | 12 | 2.06 |
PeerJ | 12 | 2.379 |
PloS one | 11 | 2.740 |
Cancer Immunol Immun | 10 | 5.44 |
Front Cell Dev Biol | 10 | 5.201 |
J Cancer Res Clin Oncol | 10 | 3.656 |
J Cell Physiol | 10 | 5.546 |
J Comput Biol | 10 | 1.05 |
BMC Med Genomics | 9 | 2.570 |
Com Chem High T Sci | 9 | 1.195 |
Clin Cancer Res | 8 | 10.11 |
Eur Rev Med Pharmaco | 8 | 3.024 |
Front Pharmacol | 8 | 4.225 |
Int J Cancer | 8 | 5.145 |
Int J Mol Sci | 8 | 4.556 |
J Exp Clin Cancer Res | 8 | 7.07 |
Bioinformatics | 7 | 5.62 |
Int J Med Sci | 7 | 2.523 |
Life Sci | 7 | 3.647 |
Brief Bioinform | 6 | 8.990 |
Cell Death & Dis | 6 | 6.304 |
J Cell Biochem | 6 | 4.237 |
J Thorac Oncol | 6 | 2.206 |
J Int Med Res | 6 | 1.29 |
生信SCI友好期刊影响因子排序：
2020生信友好期刊 | 2020-IF因子 | 接收量 |
Clin Cancer Res | 10.107 | 8.00 |
Brief Bioinform | 8.990 | 6.00 |
Theranostics | 8.579 | 14.00 |
J Exp Clin Cancer Res | 7.068 | 8.00 |
Cell Death & Dis | 6.304 | 6.00 |
Genomics | 6.205 | 14.00 |
Cancers | 6.126 | 32.00 |
Bioinformatics | 5.615 | 7.00 |
J Cell Physiol | 5.546 | 10.00 |
Cancer Immunol Immun | 5.442 | 10.00 |
Front Cell Dev Biol | 5.201 | 10.00 |
Int J Cancer | 5.145 | 8.00 |
FrontOncol | 4.848 | 48.00 |
Aging (Albany NY) | 4.831 | 34.00 |
Int J Mol Sci | 4.556 | 8.00 |
J CELL MOL MED | 4.486 | 26.00 |
J Cell Biochem | 4.237 | 6.00 |
Front Pharmacol | 4.225 | 8.00 |
CancerCell Int | 4.175 | 35.00 |
J Transl Med | 4.124 | 13.00 |
Sci Rep | 3.998 | 23.00 |
Int J Immunopharmacol | 3.943 | 31.00 |
J Cancer Res Clin Oncol | 3.656 | 10.00 |
Life Sci | 3.647 | 7.00 |
J Cancer | 3.565 | 22.00 |
Cancer Med | 3.491 | 23.00 |
Oncol Rep | 3.417 | 13.00 |
Am J Transl Res | 3.375 | 15.00 |
OncoTargets Ther | 3.337 | 26.00 |
Front Genet | 3.258 | 27.00 |
DNA Cell Biol | 3.191 | 15.00 |
BMC cancer | 3.150 | 19.00 |
Eur Rev Med Pharmaco | 3.024 | 8.00 |
Gene | 2.984 | 13.00 |
Biosci Rep | 2.942 | 23.00 |
Cancer Manag Res | 2.886 | 15.00 |
PloS one | 2.740 | 11.00 |
BMC Med Genomics | 2.570 | 9.00 |
Int J Med Sci | 2.523 | 7.00 |
PeerJ | 2.379 | 12.00 |
OncolLett | 2.311 | 49.00 |
BiomedRes Int | 2.276 | 40.00 |
J Thorac Oncol | 2.206 | 6.00 |
Mol Med Rep | 2.100 | 17.00 |
Pathol Res Pract | 2.059 | 12.00 |
Med Sci Monitor | 1.918 | 15.00 |
Exp Ther Med | 1.785 | 12.00 |
Medicine | 1.552 | 23.00 |
J Int Med Res | 1.287 | 6.00 |
Com Chem High T Sci | 1.195 | 9.00 |
J Comput Biol | 1.054 | 10.00 |
想知道高分文章idea？哈哈，多看文章多总结！下面我们列举出了最新的高分文章，影响因子均在10分以上。
文章标题（IF>10） |
MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma. |
Multigenerational maternal obesity increases the incidence of HCC in offspring via miR-27a-3p |
Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning |
Exploring prognostic indicators in the pathological images of hepatocellular carcinoma based on deep learning |
ProstaTrend-A Multivariable Prognostic RNA Expression Score for Aggressive Prostate |
FXR Isoforms Control Different Metabolic Functions in Liver Cells via Binding to |
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer |
A user guide for the online exploration and visualization of PCAWG data. |
Sex differences in oncogenic mutational processes. |
Tissue- and development-stage-specific mRNA and heterogeneous CNV signatures of human ribosomal proteins in normal and cancer samples |
TIMER2.0 for analysis of tumor-infiltrating immune cells. |
CVCDAP: an integrated platform for molecular and clinical analysis of cancer virtual cohorts |
Weakly Supervised Deep Learning for Whole Slide Lung Cancer Image Analysis. |
Reference-free deconvolution, visualization and interpretation of complex DNA methylation data using DecompPipeline, MeDeCom and FactorViz |
Epidermal Growth Factor Receptor (EGFR) as a molecular determinant of glioblastoma response to dopamine receptor 2 (DRD2) inhibitors |
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden |
TET1 promotes malignant progression of cholangiocarcinoma with IDH1 wild-type. |
Whole Exome Profiling of NSCLC Among African Americans. |
Tobacco smoking induces metabolic reprogramming of renal cell carcinoma. |
TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations |
Identification of Deleterious NOTCH Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC |
Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8 + T Cells and Elevated β-Catenin Activation Compared with Squamous Cell Carcinoma |
TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial |
A 15-Gene Immune, Stromal, and Proliferation Gene Signature that Significantly Associates with Poor Survival in Patients with Pancreatic Ductal Adenocarcinoma |
Glioblastoma TCGA mesenchymal and IGS 23 tumors are identifiable by immunohistochemistry and have an immune-phenotype indicating potential benefit from immunotherapy |
Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression |
Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma In Situ to Invasive Ductal Carcinoma |
Genomic analysis of germline variation associated with survival of colorectal cancer patients treated with chemotherapy plus biologics in CALGB/SWOG 80405 (Alliance) |
什么？10+文章太难搞！那我们再来看看5-10分都有哪些文章
影响因子在5-10分的杂志里Cancers 发布的纯生信文章最多，但是竟还是几乎没有中国单位发表的。。。好吧，下面我们只列举既对生信文章友好，又对中国单位友好的期刊Genomics、J Cell Physiol、Cancer Immunol Immunother的生信文章列表。（想投5-10分的纯生信文章，这三个期刊是首选哦！）
文章标题（10>IF>5） |
Prognostic significance of ARL9 and its methylation in low-grade glioma. |
Estimating gene expression from DNA methylation and copy number variation: A deep |
Minimum error calibration and normalization for genomic copy number analysis. |
Development and validation of a six-RNA binding proteins prognostic signature and candidate drugs for prostate cancer |
Development and validation of a 14-gene signature for prognosis prediction in hepatocellular carcinoma |
Identification and validation of a six-lncRNA prognostic signature with its ceRNA networks and candidate drugs in lower-grade gliomas |
Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironment |
Analysis of relapse-associated alternative mRNA splicing and construction of a prognostic signature predicting relapse in I-III colon cancer |
Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analysis |
Clinical and genomic characterization of neutral tumor evolution in Head and Neck Squamous Cell Carcinoma |
CancerEnD: A database of cancer associated enhancers. |
Construction and validation of a TP53-associated immune prognostic model for gastric cancer |
A pan-cancer analysis of the oncogenic role of staphylococcal nuclease domain-containing protein 1 (SND1) in human tumors |
Identifying potential DNA methylation markers in early-stage colorectal Cancer. |
A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis |
The chromosome 19 microRNA cluster, regulated by promoter hypomethylation, is associated with tumour burden and poor prognosis in patients with hepatocellular carcinoma |
DNA methylation data-based prognosis-subtype distinctions in patients with esophageal carcinoma by bioinformatic studies |
A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancer |
The prognostic value and potential subtypes of immune activity scores in three major urological cancers |
Identification of novel genes in testicular cancer microenvironment based on ESTIMATE algorithm-derived immune scores |
Comprehensive landscape of STEAP family functions and prognostic prediction value in glioblastoma |
Development and validation of a CpG island methylator phenotype-related prognostic signature for cholangiocarcinoma |
PSMC6 promotes osteoblast apoptosis through inhibiting PI3K/AKT signaling pathway activation in ovariectomy-induced osteoporosis mouse model |
Bioinformatic identification of key pathways, hub genes, and microbiota for therapeutic intervention in Helicobacter pylori infection |
Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC |
Tumor immune microenvironment in cancer patients with leukocytosis. |
Tumor-infiltrating CD39 + CD8 + T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients |
Tumour microenvironment (TME) characterization identified prognosis and immunotherapy response in muscle-invasive bladder cancer (MIBC) |
ZFHX3 mutation as a protective biomarker for immune checkpoint blockade in non-small cell lung cancer |
Immune checkpoint-related serum proteins and genetic variants predict outcomes of localized prostate cancer, a cohort study |
Anti-angiogenesis therapy overcomes the innate resistance to PD-1/PD-L1 blockade in VEGFA-overexpressed mouse tumor models |
Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8 + T cells in gastric cancer |
Comprehensive landscape of immune-checkpoints uncovered in clear cell renal cell carcinoma reveals new and emerging therapeutic targets |
Identification and validation of tumor environment phenotypes in lung adenocarcinoma by integrative genome-scale analysis |
